Occurrence of pharmaceuticals in a water supply system and related human health risk assessment

Water Research

Volumn 72, Issue , 2015, Pages 199-208

  de Jesus Gaffney, Vanessa ^a   Almeida, Cristina M M ^a,b   Rodrigues, Alexandre ^c   Ferreira, Elisabete ^c   Benoliel, Maria João ^c   Cardoso, Vitor Vale ^c  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b Laboratório de Bromatologia e Qualidade da Água   (Portugal)

^c Empresa Portuguesa das Aguas Livres SA   (Portugal)

Author keywords

Drinking water; Indicators; Pharmaceuticals; Risk assessment

Indexed keywords

GROUNDWATER; HEALTH; HEALTH RISKS; QUALITY CONTROL; RISK ASSESSMENT; SURFACE WATERS; WATER QUALITY; WATER SUPPLY; WATER SUPPLY SYSTEMS; WATER TREATMENT;

DRINKING WATER SAMPLES; DRINKING WATER SUPPLIES; HUMAN HEALTH RISK ASSESSMENT; PHARMACEUTICAL COMPOUNDS; RAW WATER; RISKS ASSESSMENTS; SURFACE WATER AND GROUNDWATERS; WATER SAMPLES; WATER SURFACE; WATER-SUPPLY SYSTEMS;

POTABLE WATER;

DRINKING WATER; DRUG; WATER POLLUTANT;

ADOLESCENT; ADULT; ANALYSIS; CHEMISTRY; CHILD; HEALTH; HUMAN; INFANT; NEWBORN; PORTUGAL; PRESCHOOL CHILD; RISK ASSESSMENT; TANDEM MASS SPECTROMETRY; WATER POLLUTANT; WATER SUPPLY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DRINKING WATER; HEALTH; HUMANS; INFANT; INFANT, NEWBORN; PHARMACEUTICAL PREPARATIONS; PORTUGAL; RISK ASSESSMENT; TANDEM MASS SPECTROMETRY; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY; YOUNG ADULT;

EID: 84930622465     PISSN: 00431354     EISSN: 18792448     Source Type: Journal    
DOI: 10.1016/j.watres.2014.10.027     Document Type: Article

References (29)

1. Bruce G., Pleus R., Snyder S. Toxicological relevance of pharmaceuticals in drinking water. Environ. Sci. Technol. 2010, 44(14):5619-5626.
2. CDC Center for Disease Control and Prevention, 2000 CDC Growth Charts for the United States: Methods and Development, Vital and Health Statistics, Series 11, Number 246 2002, http://www.cdc.gov/nchs/data/series/sr_11/sr11_246.pdf.
3. Daughton C. Pharmaceuticals as Environmental Pollutants: the Ramifications for Human Exposure, International Encyclopedia of Public Health 2008, Oxford: Academic Press, Oxford.
4. De Jongh C., et al. Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water. Sci. Total Environ. JUN 15 2012, 427:70-77. 0048-9697.
5. DEQ Water Quality: Rules and Regulations, Chapter 17 2005, Department of Environmental Quality (DEQ), Wyoming, Storage Tanks, (accessed in 11 April). http://deq.state.wy.us/shwd/stp/STPDownloads/Chapter_17.pdf.
6. Dodd M., Huang C. Transformation of the antibacterial agent sulfamethoxazole in reactions with chlorine: kinetics mechanisms, and pathways. Environ. Sci. Technol. NOV 1 2004, 38(21):5607-5615. 0013-936X.
7. EMEA.European Agency for the Evaluation of Medicinal Products Nimesulide Containing Medicinal Products. Summary of Product Characteristics 2004, (accessed in 11 April). http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Nimesulide_31/WC500013822.pdf.
8. EPA.U.S.Environmental Protection Agency (US EPA) Exposure Factors Handbook 2011, Washington DC. http://www.epa.gov/ncea/efh/pdfs/efh-complete.pdf.
9. EPA, U.S.Environmental Protection Agency Guidance on Selecting Age Groups for Monitoring and Assessing Childhood Exposures to Environmental Contaminants 2005, Risk Assessment Forum, EPA/630/P-03/003F. Available from: National Technical Information Service, Springfield, VA, and online at, Washington, DC [accessed in 11 April]. http://epa.gov/ncea.
10. Gaffney V.J., et al. Analysis of pharmaceutical compounds in waters by SPE-UPLC-ESI-MS/MS. Quím. Nova 2014, 37(1):138-149.
11. Hernando M., et al. Environmental risk assessment of emerging pollutants in water: approaches under horizontal and vertical EU legislation. Crit. Rev. Environ. Sci. Technol. 2011, 41(7):699-731. 1064-3389.
12. Huerta-Fontela M., Galceran M., Ventura F. Occurrence and removal of pharmaceuticals and hormones through drinking water treatment. Water Res. JAN 2011, 45(3):1432-1442. 0043-1354.
13. Huerta-Fontela M., Galceran M.T., Ventura F. Stimulatory drugs of abuse in surface waters and their removal in a conventional drinking water treatment plant. Environ. Sci. Technol. Sep 2008, 42(18):6809-6816. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/18853793, 0013-936X.
14. Jones O.A., et al. Pharmaceuticals: a threat to drinking water?. Trends Biotechnol. 2005, 23(4):163-167.
15. Kumar A., Chang B., Xagoraraki I. Human health risk assessment of pharmaceuticals in Water: Issues and challenges ahead. Int. J. Environ. Res. Public Health NOV 2010, 7(11):3929-3953. 1660-4601.
16. Kummerer K. The presence of pharmaceuticals in the environment due to human use - present knowledge and future challenges. J. Environ. Manag. JUN 2009, 90(8):2354-2366. 0301-4797.
17. Leung H., et al. Pharmaceuticals in tap water: human health risk assessment and proposed monitoring framework in China. Environ. Health Perspect. JUL 2013, 121(7):839-846. 0091-6765.
18. Limited T. U. Propranolol Tablets. Summary of Product Characteristics 2011, (accessed in 11 April). http://www.tevauk.com/mediafile/id/2873.pdf.
19. Littlefield N. Chronic Toxicity and Carcinogenesis Study on Sulfamethazine in Fischer 344 Rats 1988, unpublished report N° 420 from the National Center for Toxicological Research, Food and Drug Administration, Jefferson, Arkansas. Submitted to WHO by the U.S. Coordinator of the Codex Alimentarius, U.S. Department of Agriculture, Washington D.C.
20. MHRA.Medicines and Healthcare Products Regulatory Agency Indomethacin Tablets 2011, Summary of Product Characteristics (SPC), (accessed in 11 April). http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1369116150604.pdf.
21. OCS.Office of Chemical Safety, Department of Health, Australian Government ADI List: Acceptance Daily Intakes for Agriculture and Veterinary Chemicals 2013, Commonwealth Copyright, Australia.
22. Richardson S., Ternes T. Water analysis: emerging contaminants and current issues. Anal. Chem. JUN 15 2011, 83(12):4614-4648. 0003-2700.
23. Santos L., et al. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J. Hazard. Mater. MAR 15 2010, 175(1-3):45-95. 0304-3894.
24. Schwab B., et al. Human pharmaceuticals in US surface waters: a human health risk assessment. Regul. Toxicol. Pharmacol. AUG 2005, 42(3):296-312. 0273-2300.
25. skalko R., Poche P., Kwasigroch T. The toxicology of chemical interations during pregnancy in the mouse: caffeine and phenytoin. Toxicology 1984, 30(1):7-16.
26. Snyder S. Occurrence, treatment, and toxicological relevance of EDCs and pharmaceuticals in water. Ozone Sci. Eng. 2008, 30:65-69.
27. Stackelberg P.E., et al. Efficiency of conventional drinking-water-processes in removal of pharmaceuticals and other organic compounds. Sci. Total Environ. 2007, 377:255-272.
28. WHO, World Health Organization Guidelines for Drinking Water Quality 2011, WHO, Geneva, Switzerland.
29. WHO, World Health Organization Pharmaceuticals in Drinking-water 2011, WHO Press, Geneva.